HER2-positive Locally Advanced/Metastatic Gastric and/or Gastroesophageal Junction (GEJ) Adenocarcinoma in Russia
Clinical trial NCT05892926 · COMPLETED
Trial details
- NCT number
- NCT05892926
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-05-30
- Primary completion
- 2024-07-31
- Enrollment
- 204
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.